A new study published in The Lancet has found that two years of treatment with anti–interleukin-5/receptor (IL-5/R) therapy leads to durable remission, reduced oral glucocorticoid …
A recent study published in Rheumatic and Musculoskeletal Diseases Open found that elevated baseline levels of complement activation marker C3dg and complement proteases MASP-1 and MASP-3 predicted …
A new study published in The Lancet has found that nipocalimab, a neonatal Fc receptor (FcRn) blocker, significantly reduces clinical disease activity in patients with …
A new study published in Inflammopharmacology reports that L-carnitine, when administered alongside conventional disease-modifying antirheumatic drugs (DMARDs), may significantly improve clinical symptoms and reduce systemic inflammation in …
A new study published in Annals of the Rheumatic Diseases reports that patients with rheumatoid arthritis (RA) who receive Janus kinase inhibitors show a small …
A recent study published in Current Rheumatology Reviews found that high dose omega 3 supplementation significantly improved fibromyalgia pain measures and was associated with increased serum magnesium …
A new analysis published in RMD Open reports that the neutrophil percentage to albumin ratio (NPAR) is significantly associated with increased osteoarthritis risk, with diagnostic performance in …
A recent study published in Rheumatic and Musculoskeletal Diseases Open reported that nintedanib may help stabilize capillary density in patients with systemic sclerosis (SSc)-associated interstitial lung disease …
Zasocitinib, an investigational oral tyrosine kinase 2 (TYK2) inhibitor, has demonstrated significant improvements in patients with active psoriatic arthritis, according to a recent study published in Annals of …